Seeking Alpha

OncoSec Medical's (ONCS.OB) ImmunoPulse technology for administering drugs via electroporation...

OncoSec Medical's (ONCS.OB) ImmunoPulse technology for administering drugs via electroporation led to a significant change in tumor immunity in a Phase II study of patients who were given therapy called Interleukin-12 to treat metastatic melanoma. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector